- Home
- DLHC vs NTRB Comparison
DLHC vs NTRB Comparison
Compare DLHC & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLHC
- NTRB
- Stock Information
- Founded
- DLHC 1969
- NTRB 2016
- Country
- DLHC United States
- NTRB United States
- Employees
- DLHC N/A
- NTRB N/A
- Industry
- DLHC Business Services
- NTRB Industrial Specialties
- Sector
- DLHC Consumer Discretionary
- NTRB Health Care
- Exchange
- DLHC Nasdaq
- NTRB Nasdaq
- Market Cap
- DLHC 80.6M
- NTRB 93.2M
- IPO Year
- DLHC N/A
- NTRB N/A
- Fundamental
- Price
- DLHC $6.22
- NTRB $6.73
- Analyst Decision
- DLHC
- NTRB Buy
- Analyst Count
- DLHC 0
- NTRB 1
- Target Price
- DLHC N/A
- NTRB $13.00
- AVG Volume (30 Days)
- DLHC 215.6K
- NTRB 49.4K
- Earning Date
- DLHC 12-03-2025
- NTRB 12-03-2025
- Dividend Yield
- DLHC N/A
- NTRB N/A
- EPS Growth
- DLHC 80.25
- NTRB N/A
- EPS
- DLHC 0.31
- NTRB N/A
- Revenue
- DLHC $359,723,000.00
- NTRB $2,578,059.00
- Revenue This Year
- DLHC N/A
- NTRB $560.75
- Revenue Next Year
- DLHC N/A
- NTRB $588.39
- P/E Ratio
- DLHC $19.78
- NTRB N/A
- Revenue Growth
- DLHC N/A
- NTRB 42.92
- 52 Week Low
- DLHC $2.72
- NTRB $2.98
- 52 Week High
- DLHC $9.58
- NTRB $9.42
- Technical
- Relative Strength Index (RSI)
- DLHC 66.38
- NTRB 42.29
- Support Level
- DLHC $5.55
- NTRB $7.00
- Resistance Level
- DLHC $5.97
- NTRB $8.25
- Average True Range (ATR)
- DLHC 0.33
- NTRB 0.50
- MACD
- DLHC 0.05
- NTRB -0.08
- Stochastic Oscillator
- DLHC 27.80
- NTRB 13.14
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.